BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37819581)

  • 1. Low microsatellite instability: A distinct instability type in gastric cancer?
    Kohlruss M; Chakraborty S; Hapfelmeier A; Jesinghaus M; Slotta-Huspenina J; Novotny A; Sisic L; Gaida MM; Ott K; Weichert W; Pfarr N; Keller G
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17727-17737. PubMed ID: 37819581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
    Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
    J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.
    Hiltner T; Kohlruss M; Herz AL; Lorenzen S; Novotny A; Hapfelmeier A; Jesinghaus M; Slotta-Huspenina J; Sisic L; Gaida MM; Weichert W; Ott K; Keller G
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7651-7662. PubMed ID: 37000259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosensitivity and survival in gastric cancer patients with microsatellite instability.
    Oki E; Kakeji Y; Zhao Y; Yoshida R; Ando K; Masuda T; Ohgaki K; Morita M; Maehara Y
    Ann Surg Oncol; 2009 Sep; 16(9):2510-5. PubMed ID: 19565284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy.
    Li Z; Jia Y; Zhu H; Xing X; Pang F; Shan F; Li S; Wang D; Zhao F; Ma T; Wang S; Ji J
    Gastric Cancer; 2021 Nov; 24(6):1342-1354. PubMed ID: 34406546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses.
    Kim SY; Choi YY; An JY; Shin HB; Jo A; Choi H; Seo SH; Bang HJ; Cheong JH; Hyung WJ; Noh SH
    Int J Cancer; 2015 Aug; 137(4):819-25. PubMed ID: 25614197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the Efficacy of 5-Fluorouracil-Based Adjuvant Chemotherapy in Gastric Cancer by Microsatellite Instability: A Meta-Analysis.
    Zhao F; Yuan X; Ren D; Shen G; Wang Z; Zheng F; Ahmad R; Ma Z; Zhao J
    J Environ Pathol Toxicol Oncol; 2019; 38(1):21-28. PubMed ID: 30806287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent Bax frameshift mutations in gastric cancer with high but not low microsatellite instability.
    Yamamoto H; Itoh F; Fukushima H; Adachi Y; Itoh H; Hinoda Y; Imai K
    J Exp Clin Cancer Res; 1999 Mar; 18(1):103-6. PubMed ID: 10374688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
    Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection.
    An JY; Kim H; Cheong JH; Hyung WJ; Kim H; Noh SH
    Int J Cancer; 2012 Jul; 131(2):505-11. PubMed ID: 21898388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric cancer with microsatellite instability displays increased thymidylate synthase expression.
    Pereira MA; Dias AR; Ramos MFKP; Cardili L; Moraes RDR; Zilberstein B; Nahas SC; Mello ES; Ribeiro U
    J Surg Oncol; 2022 Jul; 126(1):116-124. PubMed ID: 35689583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.
    Imamura Y; Toihata T; Haraguchi I; Ogata Y; Takamatsu M; Kuchiba A; Tanaka N; Gotoh O; Mori S; Nakashima Y; Oki E; Mori M; Oda Y; Taguchi K; Yamamoto M; Morita M; Yoshida N; Baba H; Mine S; Nunobe S; Sano T; Noda T; Watanabe M
    Int J Cancer; 2021 Mar; 148(5):1260-1275. PubMed ID: 32997798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability in solitary and sporadic gastric cancer.
    Perez RO; Jacob CE; D'Ottaviano FL; Alvarenga C; Ribeiro AS; Ribeiro U; Bresciani CJ; Zilberstein B; Krieger JE; Habr-Gama A; Gama-Rodrigues JJ
    Rev Hosp Clin Fac Med Sao Paulo; 2004 Oct; 59(5):279-85. PubMed ID: 15543400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between frameshift mutations of transforming growth factor-beta type II receptor, insulin growth factor II receptor, bcl-2 associated X protein, E2F4 and microsatellite instability in gastric carcinoma].
    Chen GT; Zhu ZG; Yin HR; Liu BY; Ji J; Zhang J; Lin YZ
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):344-8. PubMed ID: 16635398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide study of microsatellite instability in advanced gastric carcinoma.
    Wu CW; Chen GD; Jiang KC; Li AF; Chi CW; Lo SS; Chen JY
    Cancer; 2001 Jul; 92(1):92-101. PubMed ID: 11443614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of neoadjuvant chemotherapy on microsatellite instability in gastric carcinoma].
    Sun XW; Zhan YQ; Li W; Xu L; Li JT; Chen XJ; Zhang RH; Xu DZ
    Ai Zheng; 2006 Dec; 25(12):1493-6. PubMed ID: 17166373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of telomere function in gastric cancers with and without microsatellite instability.
    Pascua I; Fernández-Marcelo T; Sánchez-Pernaute A; de Juan C; Head J; Torres-García AJ; Iniesta P
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):162-9. PubMed ID: 25486025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?
    Herz AL; Wisser S; Kohlruss M; Slotta-Huspenina J; Jesinghaus M; Grosser B; Steiger K; Novotny A; Hapfelmeier A; Schmidt T; Gaida MM; Weichert W; Keller G
    J Pathol Clin Res; 2022 May; 8(3):233-244. PubMed ID: 35099128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
    Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
    Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.